Discontinuing statin therapy safe, beneficial for patients with terminal illness
the ONA take:
According to a new study published in the JAMA Internal Medicine, researchers from 15 Palliative Care Research Cooperative Group member sites have found that it is acceptable for patients with cancer, heart disease, and other life-limiting illness to discontinue statin medications or begin discussions about discontinuing statin therapy.
For the study, researchers analyzed the outcomes of 381 patients with a mean age of 74 who had between 1 month and 1 year left to live. About half of participants had cancer. Researchers divided the participants into two groups and had one group continue to take statins while the other group did not.
Results showed that the 212 participants survived beyond 60 days of study initiation. Researchers found no significant difference between mortality rates of those who continued statin therapy (20.3%) versus those who discontinued statin therapy (23.8%).
In regard to cost savings, the study showed that the surviving participants would save $716 each over the trial period. The national annual savings in 2014 would have been $529 million for generic statins.
It is acceptable for patients with cancer and other life-limiting illness to discontinue statin medications.
Research published today in JAMA Internal Medicine shows that it's okay for patients with cancer, heart disease and other life-limiting illnesses to stop taking statin medications, or at least begin conversations about making that choice.
- More Than Half of Melanomas Are Self-Detected, Especially by Women
- Short-Term Intervention May Have Long-term Diet Effect in Hispanic Breast Cancer Survivors
- Low-Dose Sublingual Fentanyl Safe, Effective in Patients Receiving Lower Opioid Doses
- Childhood Cancer Linked to Poor Diet Quality in Adult Survivors
- New Research Identifies Potential Bladder Cancer Chemotherapy Side Effect
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Implementing a Distress Screening Process for Cancer Patients
- Initiating Palliative Care in the Emergency Department
- Study Identifies Factors Associated With Infection-related Complications in ALL
- Immune Checkpoint-Related Neurotoxicity May Be More Common During Combination Treatment
- New Recommendations for Secondary Prevention of Cervical Cancer
- Nonadherence to Posttreatment Imaging Follow-up Common Among Breast Cancer Survivors
- HIIT Improves Cardiorespiratory Fitness in Patients With Resectable NSCLC
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|